Sales decline 8.65% to Rs 20.37 crore
Net profit of Medicamen Biotech reported to Rs 0.51 crore in the quarter ended September 2013 as against net loss of Rs 1.21 crore during the previous quarter ended September 2012. Sales declined 8.65% to Rs 20.37 crore in the quarter ended September 2013 as against Rs 22.30 crore during the previous quarter ended September 2012. ParticularsQuarter EndedSep. 2013Sep. 2012% Var.Sales20.3722.30 -9 OPM %9.47-0.54 -PBDT1.15-0.80 LP PBT0.74-1.19 LP NP0.51-1.21 LPPowered by Capital Market - Live News
